Multiple Sclerosis study expected to soon start producing ‘powerful results’
A landmark study which seeks to identify our risk of developing Multiple Sclerosis (MS) and how we might respond to treatment has recruited 2,000 patients and is at the point where it should soon start producing “powerful results”. That’s according to consultant neurologist Brian Sweeney, who is overseeing the clinical side of the study at Cork University Hospital (CUH), one of a number of Irish sites taking part in the most comprehensive genomic study of MS ever undertaken on the island of Ireland. Read the full story here.
This website stores cookies on your computer. Some of these cookies enable this website to function and some of these cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy and Privacy Policy.